<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03163680</url>
  </required_header>
  <id_info>
    <org_study_id>G6-17</org_study_id>
    <nct_id>NCT03163680</nct_id>
  </id_info>
  <brief_title>Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers</brief_title>
  <official_title>Efficacy of Low Dose of Proton Pumb Inhabitor in Treatment Upper Gastrointestinal Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Damascus Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Damascus Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determining the efficacy of low dose of PPI in management acute peptic ulcer bleeding
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Determining the efficacy of low dose meaning 40 mg of omeprazole twice in management acute
      peptic ulcer bleeding
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 2012</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Morality</measure>
    <time_frame>within 1 week</time_frame>
    <description>Determination of mortality rate from ulcer bleeding</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rebleeding</measure>
    <time_frame>within 1 week</time_frame>
    <description>Determination of the percentage of the return of bleeding represented by recurrent melena (black, tarry stool) or recurrent Hematemesis or coffee-ground emesis or recurrent hematochezia after begin treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>need for surgery</measure>
    <time_frame>within 1 week</time_frame>
    <description>Determine the Surgery rate for treatment Bleeding ulcers within a week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>within 1 month</time_frame>
    <description>Determining the length of stay in the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood transfusions</measure>
    <time_frame>within 1 week</time_frame>
    <description>number of transfusion blood unites during admission</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Gastroduodenal Ulcer</condition>
  <condition>Marginal Ulcer</condition>
  <condition>Peptic Ulcer Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Low Dose PPI</arm_group_label>
    <description>patients with upper upper gastrointestinal bleeding were treated in low dose of proton Bump inhibitor meaning 40 mg twice daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Omeprazole 40 MG</intervention_name>
    <description>Omperazole 40 mg twice daily</description>
    <arm_group_label>Low Dose PPI</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to the gastrointestinal department of damascus hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Criteria:

        Inclusion Criteria:

        High risk ulcers defined according to the Forrest classification With respect to high-risk
        stigmata, active bleeding was defined as a continuous blood spurting (Forrest IA) oozing
        (Forrest IB) from the ulcer base. A non-bleeding visible vessel at endoscopy was defined as
        a discrete protuberance at the ulcer base(Forrest IIA).

        An adherent clot was one that was resistant to forceful irrigation or suction (Forrest
        IIB).

        Exclusion Criteria:

        ulcer was malignant non ulcerative bleeding such as angiodysplasia , a Mallory-Weiss tear
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Damascus Hospital</name>
      <address>
        <city>Damascus</city>
        <zip>+963</zip>
        <country>Syrian Arab Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Syrian Arab Republic</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2017</study_first_submitted>
  <study_first_submitted_qc>May 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2017</study_first_posted>
  <last_update_submitted>September 3, 2017</last_update_submitted>
  <last_update_submitted_qc>September 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Damascus Hospital</investigator_affiliation>
    <investigator_full_name>Marouf Alhalabi</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Gastroduodenal Ulcer</keyword>
  <keyword>Marginal Ulcer</keyword>
  <keyword>Peptic Ulcer Hemorrhage</keyword>
  <keyword>Peptic Ulcer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
    <mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Omeprazole</mesh_term>
    <mesh_term>Proton Pump Inhibitors</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

